Patients | Botulinum toxin | Placebo | t-test (p) |
---|---|---|---|
Sample size | N = 9 | N = 10 | |
Men/Women | 3/6 | 0/10 | 0.047 |
Age: mean (SD) in years | 38.1 (5.94) | 38.2 (10.27) | 0.49 |
Spinal pain intensity: mean (SD) /100 mm | 59.33 (15.71) | 58.70 (15.89) | 0.47 |
Radicular pain intensity: mean (SD) /100 mm | 42.89 (26.98) | 28.40 (27.16) | 0.13 |
Pain intensity during last month: mean (SD) /100 mm | 63.11 (25.70) | 66.70 (24.50) | 0.38 |
Pain intensity during last week: mean (SD) /100 mm | 67.67 (22.37) | 57.50 (25.63) | 0.18 |
Quebec initial score mean (SD) /100 mm | 52.56 (11.64) | 51.70 (16.55) | 0.45 |
Disability during last 8 months: mean (SD) /100 mm | 58.22 (82.29) | 151.6 (96.56) | 0.018 |
Disability during last month: mean (SD) /100 mm | 7.44 (12.99) | 13.4 (14.55) | 0.18 |
Quality of life at inclusion: mean (SD) /100 mm | 76.56 (16.41) | 65.00 (17.80) | 0.08 |
Number of days with painkillers or anti-inflammatories: number (SD) | 19.67 (13.44) | 14.1 (12.57) | 0.18 |
Paravertebral painful point pressure Right/Left/Bilateral | 4/3/2 | 4/0/6 | |
Stiffness: number | 8 | 6 | 0.08 |
Tendency to cough: number | 5 | 7 | 0.27 |
Instability: number | 9 | 8 | 0.08 |
Schober’s test: centimeter (SD) | 4.22 (1.30) | 3.95 (1.77) | 0.35 |
Hand-ground distance: centimeter (SD) | 28.60 (13.60) | 20.60 (15.60) | 0.13 |
Spinal pain: mean (SD) | 3.13 (1.46) | 3.60 (1.84) | 0.27 |
Paravertebral pain: number | 2 | 5 | 0.33 |
Lasegue sign: number | 0 | 0 | |
Pseudo-Lasegue sign: mean (SD) | 0.25 (0.46) | 0.5 (0.53) | 0.15 |
Disco-radicular conflict: number | 0 | 1 | 0.17 |
MODIC L1-L2 0/1/2/3 | 9/0/0/0 | 9/0/1/0 | 0.17 |
MODIC L2-L3 0/1/2/3 | 9/0/0/0 | 9/0/1/0 | 0.17 |
MODIC L3-L4 0/1/2/3 | 9/0/0/0 | 9/0/1/0 | 0.17 |
MODIC L4-L5 0/1/2/3 | 9/0/0/0 | 9/0/0/1 | 0.17 |
MODIC L5-S1 0/1/2/3 | 5/3/1/0 | 4/3/2/1 | 0.15 |
HADAR L1-L2 0/1/2/3 | 8/1/0/0 | 8/2/0/0 | 0.31 |
HADAR L2-L3 0/1/2/3 | 6/3/0/0 | 7/3/0/0 | 0.44 |
HADAR L3-L4 0/1/2/3 | 4/5/0/0 | 7/1/2/0 | 0.33 |
HADAR L4-L5 0/1/2/3 | 1/6/2/0 | 3/4/3/0 | 0.37 |
HADAR L5-S1 0/1/2/3 | 1/4/4/0 | 0/4/6/0 | 0.18 |
Isokinetic maximum strength: n/m (SD) | 115.33 (58.63) | 114.44 (37.63) | 0.49 |
Isokinetic endurance: n/m (SD) | 89.11 (62.50) | 77.33 (53.86) | 0.34 |
Flexors/extensors ratio at 60°: % (SD) | 123.63 (37.56) | 119.36 (49.51) | 0.42 |